Pathogenesis and Therapeutic Strategies in the Interaction between Gut Microbiota and Enterohemorrhagic Escherichia coli Infection.

Gut microbiota influences EHEC infection severity, with beneficial microbes providing resistance and certain species promoting virulence, impacting disease outcomes.

• Why it matters: Understanding how gut microbes modulate EHEC pathogenesis is crucial for developing targeted therapies to prevent or treat infections caused by this major foodborne pathogen.
• What they did: The study reviews the roles of specific microbiota members and metabolites, analyzing their interactions with EHEC through multi-omics and AI-based approaches to identify intervention points.
• The result: Insights into host-microbe-pathogen dynamics enable the design of personalized microbiota-targeted therapies, such as probiotics and fecal transplants, to enhance resistance and reduce virulence.